Colonic diverticular hemorrhage associated with the use of nonsteroidal anti-inflammatory drugs, low-dose aspirin, antiplatelet drugs, and dual therapy

Journal of Gastroenterology and Hepatology (Australia)

Volumn 29, Issue 10, 2014, Pages 1786-1793

  Nagata, Naoyoshi ^a   Niikura, Ryota ^a   Aoki, Tomonori ^a   Shimbo, Takuro ^a   Kishida, Yoshihiro ^a   Sekine, Katsunori ^a   Tanaka, Shohei ^a   Watanabe, Kazuhiro ^a   Sakurai, Toshiyuki ^a   Yokoi, Chizu ^a   Akiyama, Junichi ^a   Yanase, Mikio ^a   Mizokami, Masashi ^b   Uemura, Naomi ^a,b  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b 1 7 1 Kohnodai   (Japan)

Author keywords

Acetylsalicylic acid; Acute lower gastrointestinal bleeding; Antithrombotic drug; Colonic diverticular bleeding; Dual antiplatelet therapy

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ADVERSE EFFECTS; AGED; CHEMICALLY INDUCED; COLONOSCOPY; CROSS-SECTIONAL STUDY; DIVERTICULUM, COLON; DRINKING BEHAVIOR; DRUG COMBINATION; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; MALE; MIDDLE AGED; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK FACTOR; SMOKING; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICOAGULANTS; ASPIRIN; COLONOSCOPY; CROSS-SECTIONAL STUDIES; DIVERTICULUM, COLON; DRUG THERAPY, COMBINATION; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; SMOKING;

EID: 84911967614     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12595     Document Type: Article

References (37)

1. Tamura T, Sakaeda T, Kadoyama K, Okuno Y. Aspirin- and clopidogrel-associated bleeding complications: data mining of the public version of the FDA adverse event reporting system, AERS. Int. J. Med. Sci. 2012; 9: 441-446.
2. Conaghan PG. A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity. Rheumatol. Int. 2012; 32: 1491-1502.
3. Hansen ML, Sorensen R, Clausen MT etal. Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. Arch. Intern. Med. 2010; 170: 1433-1441.
4. Toyoda K, Yasaka M, Iwade K etal. Dual antithrombotic therapy increases severe bleeding events in patients with stroke and cardiovascular disease: a prospective, multicenter, observational study. Stroke 2008; 39: 1740-1745.
5. Masso Gonzalez EL, Patrignani P, Tacconelli S, Garcia Rodriguez LA. Variability among nonsteroidal antiinflammatory drugs in risk of upper gastrointestinal bleeding. Arthritis Rheum. 2010; 62: 1592-1601.
6. Bjarnason I, Hayllar J, MacPherson AJ, Russell AS. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology 1993; 104: 1832-1847.
7. Laine L, Smith R, Min K, Chen C, Dubois RW. Systematic review: the lower gastrointestinal adverse effects of non-steroidal anti-inflammatory drugs. Aliment. Pharmacol. Ther. 2006; 24: 751-767.
8. Longstreth GF. Epidemiology and outcome of patients hospitalized with acute lower gastrointestinal hemorrhage: a population-based study. Am. J. Gastroenterol. 1997; 92: 419-424.
9. Okamoto T, Watabe H, Yamada A, Hirata Y, Yoshida H, Koike K. The association between arteriosclerosis related diseases and diverticular bleeding. Int. J. Colorectal Dis. 2012; 27: 1161-1166.
10. Yamada A, Sugimoto T, Kondo S etal. Assessment of the risk factors for colonic diverticular hemorrhage. Dis. Colon Rectum 2008; 51: 116-120.
11. Tsuruoka N, Iwakiri R, Hara M etal. NSAIDs are a significant risk factor for colonic diverticular hemorrhage in elder patients: evaluation by a case-control study. J. Gastroenterol. Hepatol. 2011; 26: 1047-1052.
12. Niikura R, Nagata N, Yamada A, Akiyama J, Shimbo T, Uemura N. Recurrence of colonic diverticular bleeding and associated risk factors. Colorectal Dis. 2012; 14: 302-305.
13. Jansen A, Harenberg S, Grenda U, Elsing C. Risk factors for colonic diverticular bleeding: a westernized community based hospital study. World J. Gastroenterol. 2009; 15: 457-461.
14. Campbell K, Steele RJ. Non-steroidal anti-inflammatory drugs and complicated diverticular disease: a case-control study. Br. J. Surg. 1991; 78: 190-191.
15. Foutch PG. Diverticular bleeding: are nonsteroidal anti-inflammatory drugs risk factors for hemorrhage and can colonoscopy predict outcome for patients? Am. J. Gastroenterol. 1995; 90: 1779-1784.
16. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J. Clin. Epidemiol. 1996; 49: 1373-1379.
17. Aldoori WH, Giovannucci EL, Rimm EB, Wing AL, Willett WC. Use of acetaminophen and nonsteroidal anti-inflammatory drugs: a prospective study and the risk of symptomatic diverticular disease in men. Arch. Fam. Med. 1998; 7: 255-260.
18. Strate LL, Liu YL, Huang ES, Giovannucci EL, Chan AT. Use of aspirin or nonsteroidal anti-inflammatory drugs increases risk for diverticulitis and diverticular bleeding. Gastroenterology 2011; 140: 1427-1433.
19. Strate LL, Liu YL, Aldoori WH, Syngal S, Giovannucci EL. Obesity increases the risks of diverticulitis and diverticular bleeding. Gastroenterology 2009; 136: 115-122.
20. Lhewa DY, Strate LL. Pros and cons of colonoscopy in management of acute lower gastrointestinal bleeding. World J. Gastroenterol. 2012; 18: 1185-1190.
21. Laine L. Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient. Gastroenterology 2001; 120: 594-606.
22. Hreinsson JP, Gumundsson S, Kalaitzakis E, Bjornsson ES. Lower gastrointestinal bleeding: incidence, etiology, and outcomes in a population-based setting. Eur. J. Gastroenterol. Hepatol. 2013; 25: 37-43.
23. Niikura R, Nagata N, Akiyama J, Shimbo T, Uemura N. Hypertension and concomitant arteriosclerotic diseases are risk factors for colonic diverticular bleeding: a case-control study. Int. J. Colorectal Dis. 2012; 27: 1137-1143.
24. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 1987; 40: 373-383.
25. Svedlund J, Sjodin I, Dotevall G. GSRS-a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig. Dis. Sci. 1988; 33: 129-134.
26. Wiklund IK, Fullerton S, Hawkey CJ etal. An irritable bowel syndrome-specific symptom questionnaire: development and validation. Scand. J. Gastroenterol. 2003; 38: 947-954.
27. Jensen DM, Machicado GA, Jutabha R, Kovacs TO. Urgent colonoscopy for the diagnosis and treatment of severe diverticular hemorrhage. N. Engl. J. Med. 2000; 342: 78-82.
28. Zuckerman GR, Prakash C. Acute lower intestinal bleeding. part II: etiology, therapy, and outcomes. Gastrointest. Endosc. 1999; 49: 228-238.
29. Wilson RG, Smith AN, Macintyre IM. Complications of diverticular disease and non-steroidal anti-inflammatory drugs: a prospective study. Br. J. Surg. 1990; 77: 1103-1104.
30. Lanas A, Sopena F. Nonsteroidal anti-inflammatory drugs and lower gastrointestinal complications. Gastroenterol. Clin. North Am. 2009; 38: 333-352.
31. Hansen TM, Matzen P, Madsen P. Endoscopic evaluation of the effect of indomethacin capsules and suppositories on the gastric mucosa in rheumatic patients. J. Rheumatol. 1984; 11: 484-487.
32. Patrono C, Garcia Rodriguez LA, Landolfi R, Baigent C. Low-dose aspirin for the prevention of atherothrombosis. N. Engl. J. Med. 2005; 353: 2373-2383.
33. Kamal AK, Naqvi I, Husain MR, Khealani BA. Cilostazol versus aspirin for secondary prevention of vascular events after stroke of arterial origin. Cochrane Database Syst. Rev. 2011; (1): CD008076.
34. Sudlow CL, Mason G, Maurice JB, Wedderburn CJ, Hankey GJ. Thienopyridine derivatives versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients. Cochrane Database Syst. Rev. 2009; (4): CD001246.
35. Yusuf S, Zhao F, Mehta SR etal. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N. Engl. J. Med. 2001; 345: 494-502.
36. Peters RJ, Mehta SR, Fox KA etal. Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the clopidogrel in unstable angina to prevent recurrent events (CURE) study. Circulation 2003; 108: 1682-1687.
37. Strate LL. Lifestyle factors and the course of diverticular disease. Dig. Dis. 2012; 30: 35-45.